DK0472033T3 - 3,5-Diiod-L-thyronin til TSH-suppression og behandling af struma - Google Patents

3,5-Diiod-L-thyronin til TSH-suppression og behandling af struma

Info

Publication number: DK0472033T3
Authority: DK; Denmark
Prior art keywords: thyronine; diiodo; treatment; tsh; stroma
Prior art date: 1990-08-23

Application number

DK91113017.7T

Other languages

English (en)

Inventor

Claus Dr Rer Nat Dipl-Bi Horst

Original Assignee

Henning Berlin Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-23

Filing date

1991-08-02

Publication date

1996-01-29

1991-08-02 Application filed by Henning Berlin Gmbh filed Critical Henning Berlin Gmbh

1996-01-29 Application granted granted Critical

1996-01-29 Publication of DK0472033T3 publication Critical patent/DK0472033T3/da

Links

ZHSOTLOTTDYIIK-ZDUSSCGKSA-N (2S)-2-amino-3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C=C1 ZHSOTLOTTDYIIK-ZDUSSCGKSA-N 0.000 title abstract 2
230000001629 suppression Effects 0.000 title abstract 2
230000000694 effects Effects 0.000 abstract 2
206010018498 Goitre Diseases 0.000 abstract 1
201000003872 goiter Diseases 0.000 abstract 1
230000007774 longterm Effects 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Radio Relay Systems (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Microwave Tubes (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Superconductors And Manufacturing Methods Therefor (AREA)

DK91113017.7T 1990-08-23 1991-08-02 3,5-Diiod-L-thyronin til TSH-suppression og behandling af struma DK0472033T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4026600A DE4026600A1 (de)	1990-08-23	1990-08-23	Mittel zur tsh-suppression und behandlung von struma

Publications (1)

Publication Number	Publication Date
DK0472033T3 true DK0472033T3 (da)	1996-01-29

Family

ID=6412712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91113017.7T DK0472033T3 (da)	1990-08-23	1991-08-02	3,5-Diiod-L-thyronin til TSH-suppression og behandling af struma

Country Status (8)

Country	Link
US (1)	US5200428A (da)
EP (1)	EP0472033B1 (da)
JP (1)	JP2709761B2 (da)
AT (1)	ATE131729T1 (da)
DE (2)	DE4026600A1 (da)
DK (1)	DK0472033T3 (da)
ES (1)	ES2083490T3 (da)
GR (1)	GR3018705T3 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19541128C2 (de) *	1995-10-27	1997-11-27	Henning Berlin Gmbh & Co	Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US6740680B1 (en) *	1999-04-26	2004-05-25	Becton Pharma, Inc.	Pharmaceutical compositions to tetrac and methods of use thereof
ITMI20011401A1 (it)	2001-07-02	2003-01-02	Altergon Sa	Formulazioni farmaceutiche per ormoni tiroidei
ITMI20022777A1 (it) *	2002-12-27	2004-06-28	Altergon Sa	Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
ITRM20030363A1 (it) *	2003-07-24	2005-01-25	Fernando Goglia	Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
DE102010018514A1 (de)	2010-04-27	2011-10-27	Nordischer Maschinenbau Rud. Baader Gmbh + Co Kg	Vorrichtung und Verfahren zum Trennen einer Oberflächenschicht von tierischen Nahrungsmittelprodukten
CN104784427A (zh) *	2015-05-19	2015-07-22	李汶峰	一种治疗甲状腺囊肿的中药

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3102136A (en) *	1959-06-24	1963-08-27	Warner Lambert Pharmaceutical	Process of preparing diiodinated analogs of thyronine
US4673691A (en) *	1984-11-05	1987-06-16	Nicholas Bachynsky	Human weight loss inducing method
CN1011118B (zh) *	1986-06-13	1991-01-09	天津医学院附属医院	治疗白内障的眼药水的制药方法

1990
- 1990-08-23 DE DE4026600A patent/DE4026600A1/de active Granted
1991
- 1991-08-02 DK DK91113017.7T patent/DK0472033T3/da active
- 1991-08-02 ES ES91113017T patent/ES2083490T3/es not_active Expired - Lifetime
- 1991-08-02 EP EP91113017A patent/EP0472033B1/de not_active Expired - Lifetime
- 1991-08-02 AT AT91113017T patent/ATE131729T1/de not_active IP Right Cessation
- 1991-08-02 DE DE59107111T patent/DE59107111D1/de not_active Expired - Fee Related
- 1991-08-22 JP JP3235466A patent/JP2709761B2/ja not_active Expired - Lifetime
- 1991-08-23 US US07/748,882 patent/US5200428A/en not_active Expired - Fee Related
1996
- 1996-01-17 GR GR960400106T patent/GR3018705T3/el unknown

Also Published As

Publication number	Publication date
EP0472033B1 (de)	1995-12-20
DE4026600C2 (da)	1992-06-04
JPH04244022A (ja)	1992-09-01
EP0472033A3 (en)	1992-07-15
DE59107111D1 (de)	1996-02-01
ATE131729T1 (de)	1996-01-15
US5200428A (en)	1993-04-06
DE4026600A1 (de)	1992-02-27
ES2083490T3 (es)	1996-04-16
GR3018705T3 (en)	1996-04-30
JP2709761B2 (ja)	1998-02-04
EP0472033A2 (de)	1992-02-26

Similar Documents

Publication	Publication Date	Title
ES2058411T3 (es)	1994-11-01	Sustancia fr 901228 y su preparacion.
ATE138256T1 (de)	1996-06-15	Vaskularisation erlaubendes implantatmaterial
NO971206D0 (no)	1997-03-14	Forlenget-frigjöringsformulering
ES2159591T3 (es)	2001-10-16	Composicion de liberacion controlada.
NO154918C (no)	1987-01-14	Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
ES2084360T3 (es)	1996-05-01	Formulaciones de aerosoles exentas de clorofluorocarbonos.
EP0508488A3 (en)	1992-10-28	Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
NO160850C (no)	1989-06-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
FI933393A0 (fi)	1993-07-29	Agglomererade hydrofila komplex med flerfasiga frigoeringsegenskaper
FI925342L (fi)	1992-11-25	Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
CA2180535A1 (en)	1995-07-13	A method for treatment of psoriasis, by omeprazole or related compounds
ATE110957T1 (de)	1994-09-15	Pharmazeutische behandlung einer augenentwicklung.
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK0472033T3 (da)	1996-01-29	3,5-Diiod-L-thyronin til TSH-suppression og behandling af struma
JPS5753414A (en)	1982-03-30	Stabilized medicinal composition
DE59001121D1 (en)	1993-05-06	Antacidatabletten.
NO160370C (no)	1989-04-12	Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
AP9901474A0 (en)	1999-03-31	Pharmaceutical composition for treating viral diseases.
NO164095C (no)	1990-09-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
HK17880A (en)	1980-04-11	N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
NO911021L (no)	1991-09-16	Fremgangsmaate og preparat for iontoforese.
DK0669826T3 (da)	1999-05-25	(-)-Metrifonatholdigt lægemiddel
JPS5399314A (en)	1978-08-30	Therapeutic agent for nephritis
JPS545046A (en)	1979-01-16	Cephalosporin preparation for oral administration
EP0729950A4 (en)	2001-02-07	ANTI-HIV MEDICINAL PRODUCTS